MICROBOT MEDICAL INC. (NASDAQ:MBOT) Files An 8-K Financial Statements and Exhibits

MICROBOT MEDICAL INC. (NASDAQ:MBOT) Files An 8-K Financial Statements and Exhibits
Item 9.01.

Financial Statements and Exhibits.
Story continues below

(d) Exhibits

Exhibit No. Description
99.1 Updated Disclosure

Microbot Medical Inc. Exhibit
EX-99.1 2 ex99-1.htm   Exhibit 99.1   Overview   Our Company   Microbot is a pre-clinical medical device company specializing in the research,…
To view the full exhibit click here

About MICROBOT MEDICAL INC. (NASDAQ:MBOT)

Microbot Medical Inc., formerly StemCells, Inc., is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures. Its ViRob technology is an autonomous crawling micro-robot, which can be controlled remotely or within the body. The Microbot SCS device is a robotic system designed as the ventricular catheter portion of a cerebrospinal fluid (CSF) shunt system. The Company’s TipCAT is an endoscope that provides see and treat capabilities within tubular lumens in the human body, such as the colon, blood vessels and the urinary tract.

An ad to help with our costs